Experimental antiviral for COVID-19 effective in hamster study

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study. MK-4482, delivered orally, is now in human clinical trials.

from Latest Science News -- ScienceDaily https://ift.tt/3wXH0Hj

Comments

Popular posts from this blog

Seismic study reveals key reason why Patagonia is rising as glaciers melt

New method to detect and visualize sperm cells recovered from forensic evidence